A popular restaurant chain known for elaborate desserts and celebrity sightings is quietly shrinking its footprint, leaving some customers with fewer nearby locations and others with none at all. Several restaurants have closed in recent Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal With autumn officially arriving this week, Read more…
The old saying “there’s a Walmart in every town” may mostly ring true. But that doesn’t mean the company doesn’t have room for growth. Walmart is doubling down on a market that has become increasingly Read more…
Online wardrobe service Stitch Fix is set to report its Q4 2026 earnings after the closing bell on Sept. 29, 2026. The report comes amid a sluggish stretch for the company, which has seen its Read more…
For decades, Howard Marks has warned investors of risks that markets might undervalue. His latest memo raises an especially uncomfortable question: What if America’s fiscal habits eventually undermine confidence in the dollar? The Oaktree founder Read more…
Something strange happened in Silicon Valley this September. The same executives who spent years insisting artificial intelligence was safe, manageable, and good for humanity suddenly started sounding like the people warning against it. Researchers quit Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal It’s finally cooling off outside. While Read more…
Oracle employees are facing another major round of job cuts. This comes less than six months after the technology giant began eliminating positions across several parts of the country. The first wave surfaced at the Read more…
Oil spiked above $100 when the Iran war started in late February. It pulled back toward $70 by July. Then fresh attacks on shipping and energy infrastructure pushed it back above $90. Bank of America Read more…
I know the frustration that runs through the American investor community around European pharmaceutical stocks. You want exposure to a company like Novo Nordisk, one of the world’s most important drug developers, but you’re buying Read more…